Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma

• Published in: Clinical proteomics Vol. 21; no. 1; p. 2
• Main Authors: Huang, Yuqi, Ma, Sheng, Xu, Jun-Yu, Qian, Kun, Wang, Yaru, Zhang, Yi, Tan, Minjia, Xiao, Ting
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 05.01.2024; BioMed Central
• Subjects: Adenocarcinoma; Biomarkers; Biosynthesis; Cancer therapies; Care and treatment; Cell cycle; Cell growth; Clinical medicine; Datasets; Development and progression; Genetic screening; Genomes; Genomics; Health aspects; Lung cancer; Lung diseases; Medical prognosis; Mitophagy; Mortality; Mutation; Pneumothorax; Principal components analysis; Proteins; Proteomes; Proteomics; Respiratory agents; Risk assessment; Tumors; United States > US; Proteome; Solid pathological subtype; Benign lung disease cases; Lung adenocarcinoma; Prognostic biomarker

Despite recent innovations in imaging and genomic screening promotes advance in diagnosis and treatment of lung adenocarcinoma (LUAD), there remains high mortality of LUAD and insufficient understanding of LUAD biology. Our previous study performed an integrative multi-omic analysis of LUAD, filling...